{
    "clinical_study": {
        "@rank": "157994", 
        "acronym": "PEDF", 
        "arm_group": {
            "arm_group_label": "Blood draw", 
            "description": "Blood (approximately equal to 3 to 4 tablespoons) will be drawn at the Wills Eye Institute, 1 time."
        }, 
        "biospec_descr": {
            "textblock": "The level of TSP1 and PEDF in the vitreous and plasma."
        }, 
        "biospec_retention": "Samples Without DNA", 
        "brief_summary": {
            "textblock": "You are being asked to be in a research study to determine blood levels and vitreous levels\n      of compounds called thrombospondin 1 (TSP1) and pigment epithelium derived factor (PEDF).\n      These  compounds exists naturally in your body."
        }, 
        "brief_title": "A Research Study to Determine Levels of Thrombospondin-1 and Pigmented Epithelium Derived Factor Levels in Patients With Diabetes Mellitus.", 
        "completion_date": {
            "#text": "March 2014", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Diabetes", 
            "Diabetes Mellitus"
        ], 
        "condition_browse": {
            "mesh_term": "Diabetes Mellitus"
        }, 
        "detailed_description": {
            "textblock": "The hypothesis tested here is that diabetic patients that express the higher molecular\n      weight pigment epithelium-derived factor  (PEDF) isoform have lower thrombospondin-1 (TSP1)\n      level and, as a result, are at a greater risk for the development of more severe diabetic\n      retinopathy."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Ability to provide written informed consent and comply with study assessments for the\n             full duration of the study\n\n          -  Diabetes Mellitus\n\n          -  Undergoing pars plana vitrectomy for any reason\n\n        Exclusion Criteria:\n\n          -  Use of any anti-VEGF (vascular endothelial growth factor ) medications"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "N/A", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "Patients with diabetes mellitus who are undergoing pars plana vitrectomy for any reason"
            }
        }, 
        "enrollment": {
            "#text": "120", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "March 7, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01809093", 
            "org_study_id": "09-954", 
            "secondary_id": "IRB# 09-954"
        }, 
        "intervention": {
            "arm_group_label": "Blood draw", 
            "description": "3-4 tablespoons of blood will be drawn, one time.", 
            "intervention_name": "Blood draw", 
            "intervention_type": "Biological"
        }, 
        "intervention_browse": {
            "mesh_term": "Pigment epithelium-derived factor"
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "keyword": [
            "PEDF", 
            "TSP1", 
            "Thrombospondin", 
            "pigment epithelium derived factor", 
            "Wills Eye Institute", 
            "Pars plana vitrectomy", 
            "Vitreous levels", 
            "Mid Atlantic Retina", 
            "Blood draw", 
            "Blood test"
        ], 
        "lastchanged_date": "November 15, 2013", 
        "location": {
            "contact": {
                "email": "research@midatlanticretina.com", 
                "last_name": "Lisa Grande"
            }, 
            "facility": {
                "address": {
                    "city": "Philadelphia", 
                    "country": "United States", 
                    "state": "Pennsylvania", 
                    "zip": "19107"
                }, 
                "name": "Mid Atlantic Retina- Wills Eye Institute"
            }, 
            "investigator": {
                "last_name": "Marc Spirn, MD", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_groups": "1", 
        "official_title": "Modulation of Thrombospondin-1 and Pigment Epithelium Derived Factor Levels in Vitreous Fluid and Plasma of Patients With Diabetes", 
        "overall_official": {
            "last_name": "Marc Spirn, M.D.", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "March 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Your voluntary participation in this study may help determine how different TSP1 and PEDF levels correlate with diabetic eye disease.", 
            "measure": "Level of thrombospondin (TSP1) and pigment epithelium derived factor (PEDF) in the vitreous and plasma", 
            "safety_issue": "No", 
            "time_frame": "up to 6 months"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01809093"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Wills Eye", 
            "investigator_full_name": "Brian Burke, MPH", 
            "investigator_title": "Principal Investigator", 
            "responsible_party_type": "Sponsor-Investigator"
        }, 
        "source": "Wills Eye", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Brian Burke, MPH", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "March 2010", 
        "study_design": "Observational Model: Case-Only, Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "November 2013"
    }
}